NCT05560009 2025-07-10
An Imaging Agent (Fluorodopa F 18) With Positron Emission Tomography/Magnetic Resonance Imaging for Assessing Treatment Response in Patients With High-Grade Soft Tissue Sarcomas
Mayo Clinic
Completed
Clinical Trials
11 trialsNCT04183218 2024-08-23
Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes
Mayo Clinic
Completed
NCT06529588 2024-07-31
HNCs
Al-Maarif University College
Completed
NCT03989297 2020-09-02
PD-L1 and BRAF Expression in Nasopharyngeal Carcinoma
Kiang Wu Hospital
Completed
NCT02575547 2020-07-30
Effect of Chemoradiotherapy on Nutritional Status in Advanced NPC Patients
Sun Yat-sen University
Completed
NCT03935802 2019-05-02
Analysis of Circulating Epithelial Tumor Cells in Peripheral Blood in Patients With Primary Non-metastatic Breast Cancer Under Adjuvant Radiotherapy
University of Jena
Completed
NCT00704808 2015-09-09
Post Marketing Surveillance: Newly Diagnosed Glioblastoma Multiforme Treated With Radiotherapy/Temozolomide and Adjuvant Temozolomide (Study P04739)
Merck Sharp & Dohme LLC
Completed
NCT00725010 2015-09-09
Temozolomide in Concomitant Radiochemotherapy Followed by Sequential Temozolomide Chemotherapy - Observational Program (Study P04816)
Merck Sharp & Dohme LLC
Completed
NCT02372708 2015-02-26
Clinical Research on the Treatments on Advanced Malignant Melanoma by Combining in Situ Immunotherapy and Laser Therapy
Chinese PLA General Hospital
Completed
NCT00723827 2015-01-30
Temodal (Temozolomide) Post Marketing Surveillance Protocol (Study P05557AM2)
Merck Sharp & Dohme LLC
Completed
NCT00351598 2014-08-04
Lung Tumour Volume Database
Trans Tasman Radiation Oncology Group
Completed